2026年全球藥物研發實驗室自動化市場報告

近年來，藥物研發領域的實驗室自動化市場經歷了顯著成長。預計該市場規模將從2025年的67.7億美元成長到2026年的71.2億美元，複合年成長率（CAGR）為5.1%。過去幾年成長要素包括：實驗室中機械臂的引入、製藥業研發投入的增加、為減少誤差而日益成長的自動化需求、實驗室資訊管理系統的整合以及高通量篩檢技術的進步。

預計未來幾年，藥物研發領域的實驗室自動化市場將保持強勁成長，到2030年市場規模將達到87.2億美元，複合年成長率（CAGR）為5.2%。預測期內的成長要素包括人工智慧驅動的藥物研發平台的擴展、個人化醫療需求的不斷成長、雲端實驗室管理解決方案的普及、先進機器人技術在樣品處理中的應用，以及製藥和生物技術公司之間合作的加強。預測期內的關鍵趨勢包括高通量篩檢自動化、整合實驗室工作流程、藥物研發中的預測分析、實驗室流程的微型化以及雲端實驗室管理。

未來幾年，精準醫療（個人化醫療）需求的不斷成長預計將推動藥物研發市場實驗室自動化的發展。精準醫療是一種將個人在遺傳、環境和生活方式因素方面的差異納入考慮的醫療方法，旨在指導治療和預防策略。實驗室自動化能夠加快研究速度，提高實驗的可重複性，並提升精準醫療和藥物研發流程的效率，最終助力開發出針對個別患者最佳化的更有效治療方法和診斷方法。例如，根據美國非營利組織「個人化醫療聯盟」（Coalition for Personalized Medicine）2024年2月發布的報告，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化療法，較2022年的6種顯著成長。因此，對精準醫療日益成長的需求正在推動藥物研發市場實驗室自動化的發展。

藥物研發實驗室自動化領域的主要企業正致力於整合人工智慧驅動和機器人平台，以加速製劑開發並提高研發效率。人工智慧驅動和機器人輔助平台利用智慧演算法和自動化設備來簡化營運、提高準確性並加快工作流程。例如，總部位於加拿大的研究機構 Intrepid Labs 於 2025 年 5 月發布了其 Valiant 平台，這是一個由人工智慧驅動、機器人輔助的系統，旨在顯著加速藥物製劑開發。該公司已獲得超過 1,100 萬美元的資金籌措，其中包括由 AVANT BIO主導的700 萬美元種子輪融資。 Valiant 的目標是用快速、數據驅動的最佳化方法取代耗時的試驗製劑開發方法。 Valiant 可自主探索整個製劑設計空間，將開發週期從數月縮短至數天，同時提高治療效果和安全性。自 2023 年成立以來，Intrepid Labs 已與多家大型製藥公司和合約研究組織 (CRO) 建立了合作關係，並授權其專有的口服和長效注射藥物技術。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球製藥研發實驗室自動化市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 自主系統、機器人、智慧運輸
• 主要趨勢
  • 高通量篩檢的自動化
  • 整合實驗室工作流程
  • 藥物發現中的預測分析
  • 實驗過程的小型化
  • 基於雲端的實驗室管理

第5章 終端用戶產業市場分析

• 生技產業
• 製藥業
• 研究機構
• 受託研究機構（CRO）
• 學術研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球製藥研發實驗室自動化市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球藥物研發實驗室自動化市場規模、對比及成長率分析
• 全球藥物研發實驗室自動化市場表現：規模與成長，2020-2025年
• 全球藥物研發實驗室自動化市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按類型
• 自動化液體處理設備、自動化餐盤處理設備、機械臂、自動化倉庫系統及其他類型。
• 按組件
• 設備、軟體、服務
• 透過使用
• 高通量篩檢、化合物管理、樣品製備等應用
• 最終用戶
• 生物技術和製藥業、研究機構及其他最終用戶
• 按類型細分：自動化液體處理設備
• 自動化液體處理系統、多通道移液器、試劑分裝系統、自動滴定儀、液體處理工作站
• サブセグメンテーション、タイプ別：自動プレートハンドラー
• 自動微孔板處理系統、微孔盤堆垛機系統、微孔板輸送系統、微孔板分選系統
• 按類型細分：機械臂
• 機械臂、笛卡爾機器人、 SCARA機器人、關節機器人、 Delta機器人
• 按類型細分：自動化倉儲系統（ASRS）
• 自動化倉庫系統（ASRS）、垂直升降模組（VLM）、自動導引運輸車（AGV）、旋轉貨架系統、高密度儲存系統
• 按類型細分：其他類型
• 自動化樣品製備系統、實驗室資訊管理系統（LIMS）、微陣列處理器、自動化篩檢系統

第10章 區域與國別分析

• 全球製藥研發實驗室自動化市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年預測、2035年預測
• 全球製藥研發實驗室自動化市場：按國家/地區分類，實際結果和預測，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 藥物研發實驗室自動化市場：競爭格局及市場佔有率（2024 年）
• 藥物研發實驗室自動化市場：公司估值矩陣
• 藥物研發實驗室自動化市場：公司概況
  • Thermo Fisher Scientific Inc.
  • Abbott Diagnostics
  • Roche Holdings Inc.
  • Beckman Coulter
  • Siemens Healthineers

第37章 其他大型企業和創新企業

• Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc.

第38章 世界の市場競合ベンチマーキングとダッシュボード

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年藥物研發實驗室自動化市場：提供新機會的國家
• 2030年藥物研發實驗室自動化市場：新興機會細分領域
• 2030年藥物研發實驗室自動化市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第41章附錄

Lab automation in drug discovery involves the use of advanced technologies and robotics to streamline and improve laboratory processes related to the development and research of new drugs. It is employed to greatly increase the speed and success rate of drug discovery by automating repetitive tasks and integrating sophisticated instruments and software.

The primary types of lab automation in drug discovery include automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, and others. Automated liquid handlers are devices designed to automatically dispense and manage liquids, commonly used in laboratories for precise and efficient tasks such as pipetting and dilution. The various components include instruments, software, and services, which are applied in several areas such as high-throughput screening, compound management, sample preparation, and more. These systems are utilized by a range of end users, including biotechnology and pharmaceutical companies, research institutes, and others.

Tariffs have affected the lab automation in drug discovery market by increasing the cost of importing sophisticated robotic systems, instruments, and software, leading to higher operational costs for pharmaceutical and biotechnology companies. Asia-Pacific regions, particularly China, India, and Taiwan, which are major manufacturing hubs for lab automation equipment, are most impacted. Segments such as robotic arms, automated liquid handlers, and ASRS are particularly vulnerable. However, tariffs have encouraged local manufacturing and sourcing strategies, driving innovation and cost optimization in lab automation solutions.

The lab automation in drug discovery market research report is one of a series of new reports from The Business Research Company that provides lab automation in drug discovery market statistics, including lab automation in drug discovery industry global market size, regional shares, competitors with a lab automation in drug discovery market share, detailed lab automation in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in drug discovery industry. This lab automation in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab automation in drug discovery market size has grown strongly in recent years. It will grow from $6.77 billion in 2025 to $7.12 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to adoption of robotic arms in laboratories, increasing investment in pharmaceutical r&d, rise in demand for automation to reduce errors, integration of lab information management systems, growth in high-throughput screening technologies.

The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $8.72 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to expansion of ai-driven drug discovery platforms, increasing demand for personalized medicine, growth in cloud-based lab management solutions, adoption of advanced robotics for sample handling, rising collaborations between pharma and biotech companies. Major trends in the forecast period include high-throughput screening automation, integrated laboratory workflows, predictive analytics in drug discovery, miniaturization of lab processes, cloud-based lab management.

The growing demand for precision medicine is expected to drive the expansion of lab automation in the drug discovery market in the coming years. Precision medicine, also referred to as personalized medicine, is a medical approach that considers individual differences in genetics, environment, and lifestyle to guide treatment and prevention strategies. Lab automation enhances research speed, increases experimental reproducibility, and improves the efficiency of precision medicine and drug discovery processes, ultimately supporting the development of more effective therapies and diagnostics tailored to individual patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a notable increase from six approvals in 2022. Therefore, the increasing demand for precision medicine is contributing to the growth of lab automation in the drug discovery market.

Major companies operating in lab automation for drug discovery are emphasizing the integration of AI-driven and robotics-based platforms to accelerate formulation development and enhance R&D efficiency. AI-powered and robot-assisted platforms leverage smart algorithms and automated machinery to streamline tasks, increase precision, and accelerate workflows. For instance, in May 2025, Intrepid Labs, a Canada-based research laboratory, launched its Valiant platform, an AI-driven and robotics-enabled system designed to significantly speed up drug formulation development. Supported by over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company aims to replace slow, trial-and-error formulation methods with rapid, data-driven optimization. Valiant autonomously explores full formulation design spaces, reducing timelines from months to days while enhancing therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has formed partnerships with major pharmaceutical companies and CROs and is also developing proprietary oral and long-acting injectable technologies for licensing.

In March 2023, Brooks Automation, a US-based automation solutions company, acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. Through this acquisition, Brooks aims to expand its lab automation presence in clinical diagnostics and advance technological capabilities, significantly impacting lab automation in drug discovery. Aim Lab Automation Technologies Pty Ltd. is an Australia-based company that provides robotic automation instruments and modules, along with automation solutions designed to enhance drug discovery laboratory processes.

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation in drug discovery market consists of revenues earned by entities by providing services such as compound screening, assay development, high-throughput screening, data analysis, and optimization of drug candidates. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in drug discovery market also includes sales of robotics and automated workstations, screening systems, plate readers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation In Drug Discovery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lab automation in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab automation in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab automation in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Automated Liquid Handlers; Automated Plate Handlers; Robotic Arms; Automated Storage And Retrieval Systems; Other Types
• 2) By Component: Instruments; Software; Services
• 3) By Application: High-Throughput Screening; Compound Management; Sample Preparation; Other Applications
• 4) By End-User: Biotechnology And Pharmaceutical Industries; Research Institutes; Other End-Users
• Subsegments:
• 1) By Automated Liquid Handlers: Automated Liquid Handlers; Multi-Channel Pipettes; Reagent Dispensing Systems; Automated Titrators; Liquid Handling Workstations
• 2) By Automated Plate Handlers: Automated Plate Handlers; Microplate Stacker Systems; Plate Transportation Systems; Plate Sorting Systems
• 3) By Robotic Arms: Robotic Arms; Cartesian Robots; SCARA Robots; Articulated Robots; Delta Robots
• 4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS); Vertical Lift Modules (VLM); Automated Guided Vehicles (AGVs); Carousel-Based Systems; High-Density Storage Systems
• 5) By Other Types: Automated Sample Preparation Systems; Laboratory Information Management Systems (LIMS); Microarray Processors; Automated Screening Systems
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Diagnostics; Roche Holdings Inc.; Beckman Coulter; Siemens Healthineers; Becton Dickinson and Company; Agilent Technologies Inc.; PerkinElmer Inc.; Endress+Hauser; Shimadzu Corporation; Waters Corporation; Bio-Rad Laboratories Inc.; QIAGEN; Beckhoff Automation GmbH & Co. KG; Eppendorf AG; Tecan Group Ltd.; Brooks Automation Inc.; Hamilton Company; Hudson Robotics Inc.; OpenTrons Labworks Inc.; Quanterix Corporation; The Technology Partnership; HighRes Biosolutions Inc.; Biosero Inc.; Peak Analysis and Automation Ltd.; Aurora Biomed Inc.; Synchron Lab Automation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Lab Automation In Drug Discovery Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Lab Automation In Drug Discovery Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Lab Automation In Drug Discovery Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Lab Automation In Drug Discovery Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
• 4.2. Major Trends
  • 4.2.1 High-Throughput Screening Automation
  • 4.2.2 Integrated Laboratory Workflows
  • 4.2.3 Predictive Analytics In Drug Discovery
  • 4.2.4 Miniaturization Of Lab Processes
  • 4.2.5 Cloud-Based Lab Management

5. Lab Automation In Drug Discovery Market Analysis Of End Use Industries

• 5.1 Biotechnology Industries
• 5.2 Pharmaceutical Industries
• 5.3 Research Institutes
• 5.4 Contract Research Organizations (Cros)
• 5.5 Academic Laboratories

6. Lab Automation In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lab Automation In Drug Discovery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Lab Automation In Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Lab Automation In Drug Discovery Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Lab Automation In Drug Discovery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Lab Automation In Drug Discovery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lab Automation In Drug Discovery Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lab Automation In Drug Discovery Market Segmentation

• 9.1. Global Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
• 9.2. Global Lab Automation In Drug Discovery Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Instruments, Software, Services
• 9.3. Global Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
• 9.4. Global Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
• 9.5. Global Lab Automation In Drug Discovery Market, Sub-Segmentation Of Automated Liquid Handlers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
• 9.6. Global Lab Automation In Drug Discovery Market, Sub-Segmentation Of Automated Plate Handlers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
• 9.7. Global Lab Automation In Drug Discovery Market, Sub-Segmentation Of Robotic Arms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
• 9.8. Global Lab Automation In Drug Discovery Market, Sub-Segmentation Of Automated Storage And Retrieval Systems (ASRS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
• 9.9. Global Lab Automation In Drug Discovery Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

10. Lab Automation In Drug Discovery Market Regional And Country Analysis

• 10.1. Global Lab Automation In Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Lab Automation In Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lab Automation In Drug Discovery Market

• 11.1. Asia-Pacific Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lab Automation In Drug Discovery Market

• 12.1. China Lab Automation In Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lab Automation In Drug Discovery Market

• 13.1. India Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lab Automation In Drug Discovery Market

• 14.1. Japan Lab Automation In Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lab Automation In Drug Discovery Market

• 15.1. Australia Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lab Automation In Drug Discovery Market

• 16.1. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lab Automation In Drug Discovery Market

• 17.1. South Korea Lab Automation In Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lab Automation In Drug Discovery Market

• 18.1. Taiwan Lab Automation In Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lab Automation In Drug Discovery Market

• 19.1. South East Asia Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lab Automation In Drug Discovery Market

• 20.1. Western Europe Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lab Automation In Drug Discovery Market

• 21.1. UK Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lab Automation In Drug Discovery Market

• 22.1. Germany Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lab Automation In Drug Discovery Market

• 23.1. France Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lab Automation In Drug Discovery Market

• 24.1. Italy Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lab Automation In Drug Discovery Market

• 25.1. Spain Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lab Automation In Drug Discovery Market

• 26.1. Eastern Europe Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lab Automation In Drug Discovery Market

• 27.1. Russia Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lab Automation In Drug Discovery Market

• 28.1. North America Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lab Automation In Drug Discovery Market

• 29.1. USA Lab Automation In Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lab Automation In Drug Discovery Market

• 30.1. Canada Lab Automation In Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lab Automation In Drug Discovery Market

• 31.1. South America Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lab Automation In Drug Discovery Market

• 32.1. Brazil Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lab Automation In Drug Discovery Market

• 33.1. Middle East Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lab Automation In Drug Discovery Market

• 34.1. Africa Lab Automation In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Lab Automation In Drug Discovery Market, Segmentation By Type, Segmentation By Component, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lab Automation In Drug Discovery Market Regulatory and Investment Landscape

36. Lab Automation In Drug Discovery Market Competitive Landscape And Company Profiles

• 36.1. Lab Automation In Drug Discovery Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Lab Automation In Drug Discovery Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Lab Automation In Drug Discovery Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Abbott Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Beckman Coulter Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

37. Lab Automation In Drug Discovery Market Other Major And Innovative Companies

• Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc.

38. Global Lab Automation In Drug Discovery Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lab Automation In Drug Discovery Market

40. Lab Automation In Drug Discovery Market High Potential Countries, Segments and Strategies

• 40.1 Lab Automation In Drug Discovery Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Lab Automation In Drug Discovery Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Lab Automation In Drug Discovery Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer